<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02102165</url>
  </required_header>
  <id_info>
    <org_study_id>BIG 14-01</org_study_id>
    <secondary_id>1408-BCG</secondary_id>
    <secondary_id>GBG 85</secondary_id>
    <secondary_id>ICR-CTSU/2014/10050</secondary_id>
    <nct_id>NCT02102165</nct_id>
  </id_info>
  <brief_title>AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.</brief_title>
  <acronym>AURORA</acronym>
  <official_title>AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Breast International Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Breast European Adjuvant Studies Team</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Frontier Science &amp; Technology Research Foundation, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Breast International Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This program initially aims to recruit 1300 breast cancer patients from a large number of
      hospitals across Europe. Eligible patients are those who are 18 or older, either female or
      male, and who have not received more than 1 type of treatment from the time metastases were
      discovered, metastasi(e)s has just been diagnosed or their disease has come back (disease
      relapse). Biopsy samples from both the primary and metastatic (or relapsed) tumor will be
      collected for central analyses, together with blood, serum and plasma samples. Any samples
      not analyzed immediately will be stored in an independent bio-repository to enable future
      (not yet defined) research aimed at better understanding metastatic breast cancer.

      In summary, the main objectives of AURORA are to better understand the genetic aberrations in
      metastatic breast cancer and to discover the mechanisms of response or resistance to therapy,
      in order to ultimately identify the &quot;right therapy for each individual patient&quot;. At the same
      time, patients with genetic aberrations that are being targeted by new drugs in development
      will be offered the possibility to participate in clinical trials, when approved and
      available in their countries. Ultimately, the aim of AURORA is to improve the outcomes of all
      patients diagnosed with metastatic breast cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Anticipated">January 2029</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Metastatic Breast Cancer (MBC) understanding</measure>
    <time_frame>1 year after end of acrrual</time_frame>
    <description>To improve the understanding of MBC by performing high coverage Targeted Gene Sequencing (TGS) and RNA sequencing on matched primary and metastatic samples to explore tumor heterogeneity, clonal evolution and transcriptional changes associated with mutational and copy number variation (CNV) patterns.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Building new therapeutic hypotheses</measure>
    <time_frame>1 year after end of accrual and subsequently during follow up period of 10 years</time_frame>
    <description>To build new therapeutic hypotheses based on findings generated by Targeted Gene Sequencing (TGS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' prognosis determination</measure>
    <time_frame>1 year after end of accrual and subsequently during follow up period of 10 years</time_frame>
    <description>To evaluate the prognostic relevance of genomic alterations detected in tumor metastatic biopsies and archived primary tissue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification of &quot;exceptional responders&quot; and &quot;rapid progressors&quot;; the outlier patients</measure>
    <time_frame>1 year after end of accrual and subsequently during follow up period of 10 years</time_frame>
    <description>To discover biomarkers of response and/or resistance to systemic therapy using genomic and transcriptomics data of &quot;exceptional responders&quot; and &quot;rapid progressors&quot; (collectively referred to as &quot;outliers&quot;, as defined in the AURORA protocol)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility of implementing a global molecular screening platform for MBC</measure>
    <time_frame>1 year after end of accrual</time_frame>
    <description>To provide evidence that can contribute in assessing the feasibility of implementing a global molecular screening platform of MBC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between molecular alterations and standardly assessed efficacy endpoints</measure>
    <time_frame>1 year after end of accrual and subsequently during follow up period of 10 years</time_frame>
    <description>To correlate molecular alterations in patients with the efficacy endpoints (response rate, progression-free survival and overall survival) set forth in clinical study protocols.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient identification to match with biomarker-driven clinical trials</measure>
    <time_frame>on ongoing basis during 3 years' patient recruitment</time_frame>
    <description>To identify patients with candidate driver alterations in their tumors that can be matched to biomarker-driven clinical trials.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Metastatic Breast Cancer</condition>
  <arm_group>
    <arm_group_label>metastatic lesion biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>biopsy of metastatic lesion will be performed at program inclusion or maximum 6 months prior to inclusion. Sample of primary tumor must be available at inclusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>metastatic lesion biopsy</intervention_name>
    <description>a medical test commonly performed by a surgeon or an interventional radiologist in order to collect tissues for examination; in this case from a metastatic lesion</description>
    <arm_group_label>metastatic lesion biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women or men with metastatic or locally relapsed breast cancer manageable with
             systemic therapy

          2. Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1.

          3. Written informed consent prior to enrollment into the program.

          4. Patient aged â‰¥ 18 years

          5. Patient agrees to provide archived primary tumor tissue

          6. Patient agrees to provide newly collected metastatic lesions tissue samples (archived
             material up to 6 months is allowed provided both Formalin Fixed Paraffin Embedded
             (FFPE) block and Frozen Tissue are available and were collected from the same lesion
             at the same time)

          7. Patient agrees to provide blood samples

        Exclusion Criteria:

          1. The patient has received more than 1 line of systemic therapy (any type) in the
             metastatic setting

          2. Patients who have received prior palliative radiotherapy to the only site that is
             accessible to biopsy

          3. Patients with bone-only metastatic disease

          4. Patients with brain-only metastatic disease, unless surgical excision is planned (in
             which case tissue will be collected for AURORA purpose)

          5. Known presence of severe hematopoietic, renal, and/or hepatic dysfunction (according
             to the local PI)

          6. Platelet count&lt;100 000/mm3, INR&gt;1.5 (international normalized ratio; blood clotting
             time) , Albumin&lt;30

          7. Previous or current malignancies of other histologies within the last 5 years, with
             the exception of in situ carcinoma of the cervix, and adequately treated basal cell or
             squamous cell carcinoma of the skin

          8. Any anti-VEGF (vascular endothelial growth factor) or anti-VEGFR (vascular endothelial
             growth factor receptor) treatment administered less than 4 weeks before new biopsy
             procedure or no appropriate wash-out period for patients on anticoagulation therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Aftimos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Jules Bordet, Brussels, Belgium</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mafalda Oliveira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Vall d'Hebron,Barcelona, Catalonia, Spain</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>AURORA BIG HQ</last_name>
    <email>aurora.bighq@bigagainstbc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut Jules Bordet</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires St-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Grand Hopital Charleroi</name>
      <address>
        <city>Charleroi</city>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>UZA, Antwerp University Hospital</name>
      <address>
        <city>Edegem</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de LiÃ¨ge</name>
      <address>
        <city>LiÃ¨ge</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique et MaternitÃ© Sainte-Elisabeth (CMSE - Namur)</name>
      <address>
        <city>Namur</city>
        <zip>5000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sint-Augustinus</name>
      <address>
        <city>Wilrijk</city>
        <zip>2610</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Luisenkrankenhaus</name>
      <address>
        <city>DÃ¼sseldorf</city>
        <zip>40235</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kliniken Essen-Mitte, Klinik fÃ¼r Senologie/ Brustzentrum</name>
      <address>
        <city>Essen</city>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Medical Center Freiburg</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Schleswig-Holstein / Campus Luebeck</name>
      <address>
        <city>Luebeck</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sana Klinikum Offenbach</name>
      <address>
        <city>Offenbach</city>
        <zip>63069</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Oldenburg gGmbH</name>
      <address>
        <city>Oldenburg</city>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Landspitali</name>
      <address>
        <city>ReykjavÃ­k</city>
        <zip>101</zip>
        <country>Iceland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale degli Infermi - S.O.C.Oncologia</name>
      <address>
        <city>Biella</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale di Bolzano - Oncologia Medica</name>
      <address>
        <city>Bolzano</city>
        <zip>39100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale Ramazzini di Carpi</name>
      <address>
        <city>Carpi</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Az. Istituti Ospitalieri di Cremona</name>
      <address>
        <city>Cremona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>IRCCS AOU San Martino-IST</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ULSS 21 Legnago</name>
      <address>
        <city>Legnago</city>
        <zip>37045</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Istituto Europeo di Oncologia</name>
      <address>
        <city>Milano</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>UOC Oncologia Medica - AOU Parma</name>
      <address>
        <city>Parma</city>
        <zip>43126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>IRCCS Az Ospedaliera S.Maria Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Luxembourg</city>
        <zip>1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Onkologii - Instytut im. Marii Sklodowskiej-Curie</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Champalimaud Foundation</name>
      <address>
        <city>Lisboa</city>
        <zip>1400-038</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Complexo Hospitalario Universitario A CoruÃ±a</name>
      <address>
        <city>A CoruÃ±a</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr Rosell Oncology Institute, QuirÃ³n Dexeus University Hospital</name>
      <address>
        <city>Barcelona</city>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Consorcio Hospitalario Provincial de CastellÃ³n</name>
      <address>
        <city>CastellÃ³n</city>
        <zip>12002</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital San Pedro de Alcantara</name>
      <address>
        <city>CÃ¡ceres</city>
        <zip>10003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Arnau de Vilanova</name>
      <address>
        <city>Lleida</city>
        <zip>25198</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Madrid</city>
        <zip>28033</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro Integral OncolÃ³gico Clara Campa</name>
      <address>
        <city>Madrid</city>
        <zip>28050</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocio</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto Valenciano de OncologÃ­a</name>
      <address>
        <city>Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ryhov County Hospital</name>
      <address>
        <city>JÃ¶nkÃ¶ping</city>
        <zip>55185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Baden</name>
      <address>
        <city>Baden</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Inselspital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Graubuenden</name>
      <address>
        <city>Chur</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Luzerner Kantonsspital, Division of Medical Oncology</name>
      <address>
        <city>Lucerne</city>
        <zip>6003</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital - University Hospitals Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospitals Bristol NHS Foundation Trust</name>
      <address>
        <city>Bristol</city>
        <zip>BS2 8HW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Cornwall Hospital - Royal Cornwall Hospitals NHS Trust</name>
      <address>
        <city>Cornwall</city>
        <zip>TR1 3LJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>NHS Tayside, Ninewells Hospital</name>
      <address>
        <city>Dundee</city>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Edinburgh Cancer Centre - Western General Hospital</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH4 2XU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Beatson West of Scotland Cancer Centre</name>
      <address>
        <city>Glasgow</city>
        <zip>G12 0YN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Christie NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospital NHS Trust</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Velindre NHS Trust</name>
      <address>
        <city>South Glamorgan</city>
        <zip>CF15 7QZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Singleton Hospital - ABM University Health Board</name>
      <address>
        <city>Swansea</city>
        <zip>SA2 8QA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yeovil District Hospital NHS Foundation Trust</name>
      <address>
        <city>Yeovil, Somerset</city>
        <zip>BA21 4AT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Iceland</country>
    <country>Italy</country>
    <country>Luxembourg</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.bigagainstbreastcancer.org</url>
    <description>sponsor's website</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2014</study_first_submitted>
  <study_first_submitted_qc>March 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2014</study_first_posted>
  <last_update_submitted>March 21, 2018</last_update_submitted>
  <last_update_submitted_qc>March 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aurora</keyword>
  <keyword>breast cancer</keyword>
  <keyword>metastatic</keyword>
  <keyword>molecular screening</keyword>
  <keyword>targeted gene sequencing</keyword>
  <keyword>molecular aberrations</keyword>
  <keyword>exploratory</keyword>
  <keyword>biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

